User contributions for Ruthdonners
Jump to navigation
Jump to search
- 03:00, 24 October 2009 diff hist −3 m The Future of R&D in Pharmaceutical Industry in 2025
- 14:29, 23 October 2009 diff hist +30 m The Future of R&D in Pharmaceutical Industry in 2025 →Scenario tree
- 14:27, 23 October 2009 diff hist +32 N File:FinalScenarioTree.ppt This is the final scenario tree. current
- 14:23, 23 October 2009 diff hist −253 m The Future of R&D in Pharmaceutical Industry in 2025
- 19:37, 15 October 2009 diff hist +27 m RSM EMBA 2009 Scenarios →Will attend
- 18:51, 15 October 2009 diff hist +21 m RSM EMBA 2009 Scenarios →Will attend
- 04:38, 15 October 2009 diff hist +168 The Future of R&D in Pharmaceutical Industry in 2025 →Scenario tree
- 04:36, 15 October 2009 diff hist +119 Prevention is the cure →2015-2020
- 04:33, 15 October 2009 diff hist +170 Prevention is the cure →2010-2015
- 04:31, 15 October 2009 diff hist +38 The Future of R&D in Pharmaceutical Industry in 2025 →Scenario tree
- 04:29, 15 October 2009 diff hist +35 N File:Scenario tree version1.ppt First try for a scenario tree model current
- 04:04, 15 October 2009 diff hist +239 The Future of R&D in Pharmaceutical Industry in 2025
- 04:01, 15 October 2009 diff hist +5,579 Healthcare system reform
- 03:39, 15 October 2009 diff hist +80 The Future of R&D in Pharmaceutical Industry in 2025 →Scenarios.
- 03:37, 15 October 2009 diff hist −182 m The Future of R&D in Pharmaceutical Industry in 2025 →Scenarios.
- 03:37, 15 October 2009 diff hist −324 Alternative Healthcare system reform Removing all content from page current
- 03:36, 15 October 2009 diff hist −3,070 Alternative Healthcare system reform →Developments in time
- 18:29, 13 October 2009 diff hist −1 m Prevention is the cure
- 18:27, 13 October 2009 diff hist +2,970 N Prevention is the cure New page: '''Work under construction. In case you have any questions, additions or comments, please do not edit these pages, but you are more than welcome to [mailto:ruthdonners@hotmail.com contact ...
- 18:27, 13 October 2009 diff hist −2,970 m Pharma R&D: from cure to prevention Removing all content from page current
- 18:26, 13 October 2009 diff hist −13 m The Future of R&D in Pharmaceutical Industry in 2025 →Scenarios.
- 18:25, 13 October 2009 diff hist +2,970 N Pharma R&D: from cure to prevention New page: '''Work under construction. In case you have any questions, additions or comments, please do not edit these pages, but you are more than welcome to [mailto:ruthdonners@hotmail.com contact ...
- 18:25, 13 October 2009 diff hist −2,964 Different focus in pharma R&D from cure to prevention Removing all content from page current
- 18:24, 13 October 2009 diff hist −12 m The Future of R&D in Pharmaceutical Industry in 2025 →Scenarios.
- 11:13, 11 October 2009 diff hist +1 m Pharma Valley →Developments in time
- 11:05, 11 October 2009 diff hist +1,351 Cocktail bar: personalised medicine →Developments in time
- 18:50, 3 October 2009 diff hist 0 m The Future of R&D in Pharmaceutical Industry in 2025 →Scenarios.
- 18:50, 3 October 2009 diff hist +98 m The Future of R&D in Pharmaceutical Industry in 2025 →Scenarios.
- 18:49, 3 October 2009 diff hist +392 Nm Pharma Valley New page: '''Work under construction. In case you have any questions, additions or comments, please do not edit these pages, but you are more than welcome to [mailto:ruthdonners@hotmail.com contact ...
- 18:48, 3 October 2009 diff hist +398 Nm Healthcare system reform New page: '''Work under construction. In case you have any questions, additions or comments, please do not edit these pages, but you are more than welcome to [mailto:ruthdonners@hotmail.com contact ...
- 18:46, 3 October 2009 diff hist +107 m Cocktail bar: personalised medicine
- 18:46, 3 October 2009 diff hist +73 m Cocktail bar: personalised medicine
- 18:44, 3 October 2009 diff hist +206 m Different focus in pharma R&D from cure to prevention
- 18:43, 3 October 2009 diff hist +205 Nm Cocktail bar: personalised medicine New page: '''Work under construction. In case you have any questions, additions or comments, please do not edit these pages, but you are more than welcome to [mailto:ruthdonners@hotmail.com contact ...
- 18:42, 3 October 2009 diff hist −24 The Future of R&D in Pharmaceutical Industry in 2025 →Scenarios.
- 18:41, 3 October 2009 diff hist +173 m The Future of R&D in Pharmaceutical Industry in 2025 →Scenarios.
- 05:04, 3 October 2009 diff hist −1 m Different focus in pharma R&D from cure to prevention →Developments in time
- 05:03, 3 October 2009 diff hist +2,012 N Different focus in pharma R&D from cure to prevention New page: R&D of pharma will go to put part of its focus on establishing health claims for preventative formulations, like neutraceuticals and supplements<br> ==Developments in time== ===2010-2015==...
- 04:49, 3 October 2009 diff hist +96 The Future of R&D in Pharmaceutical Industry in 2025 →Scenarios.
- 04:27, 3 October 2009 diff hist +557 The Future of R&D in Pharmaceutical Industry in 2025 →Research Questions.
- 03:33, 19 September 2009 diff hist −90 m The Future of R&D in Pharmaceutical Industry in 2025
- 15:11, 18 September 2009 diff hist −4 m Changing business models for pharmaceutical industry
- 14:54, 13 September 2009 diff hist +945 Logistics/Distribution current
- 14:41, 13 September 2009 diff hist +44 m Legal Restrictions for Biotech increasing in certain countries, decreasing in others →Enablers:
- 07:20, 13 September 2009 diff hist −2 m Legal Restrictions for Biotech increasing in certain countries, decreasing in others
- 07:20, 13 September 2009 diff hist +3 Legal Restrictions for Biotech increasing in certain countries, decreasing in others
- 07:18, 13 September 2009 diff hist +418 Legal Restrictions for Biotech increasing in certain countries, decreasing in others
- 07:12, 13 September 2009 diff hist −4 m Legal Restrictions for Biotech increasing in certain countries, decreasing in others
- 07:12, 13 September 2009 diff hist 0 m Legal Restrictions for Biotech increasing in certain countries, decreasing in others
- 07:11, 13 September 2009 diff hist 0 m Legal Restrictions for Biotech increasing in certain countries, decreasing in others